# Hexcel Corp: overview

HXL · NYSE · CIK 717605 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hxl.md) · [Financials](/companies/hxl/financials.md) · [Filings](/companies/hxl/filings.md) · [Insiders](/companies/hxl/insiders.md)

Latest reported revenue: [$496.4m](/filings/0001193125-26-427907.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 21, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-427907).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [474 d](/filings/0001193125-26-046377.md) | [457](/filings/0001193125-26-170597.md) | [490](/filings/0001193125-26-323941.md) | [456](/filings/0001193125-26-427907.md) | [491 d](/filings/0001193125-26-046377.md) | [502](/filings/0001193125-26-170597.md) | [529](/filings/0001193125-26-323941.md) | [496](/filings/0001193125-26-427907.md) |
| Gross margin | % | [25.0% d](/filings/0001193125-26-046377.md) | [22.4%](/filings/0001193125-26-170597.md) | [22.8%](/filings/0001193125-26-323941.md) | [21.9%](/filings/0001193125-26-427907.md) | [24.6% d](/filings/0001193125-26-046377.md) | [26.9%](/filings/0001193125-26-170597.md) | [26.1%](/filings/0001193125-26-323941.md) | [23.3%](/filings/0001193125-26-427907.md) |
| Operating margin | % | [1.9% d](/filings/0001193125-26-046377.md) | [9.7%](/filings/0001193125-26-170597.md) | [6.1%](/filings/0001193125-26-323941.md) | [7.9%](/filings/0001193125-26-427907.md) | [12.5% d](/filings/0001193125-26-046377.md) | [11.5%](/filings/0001193125-26-170597.md) | [13.7%](/filings/0001193125-26-323941.md) | [11.0%](/filings/0001193125-26-427907.md) |
| Net margin | % | [1.2% d](/filings/0001193125-26-046377.md) | [6.3%](/filings/0001193125-26-427907.md) | [2.8%](/filings/0001193125-26-427907.md) | [4.5%](/filings/0001193125-26-427907.md) | [9.4% d](/filings/0001193125-26-046377.md) | [7.4%](/filings/0001193125-26-427907.md) | [9.3%](/filings/0001193125-26-427907.md) | [7.8%](/filings/0001193125-26-427907.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [144 d](/filings/0001193125-26-046377.md) | [(54.6)](/filings/0001193125-26-170597.md) | [8.0 d](/filings/0001193125-26-323941.md) | [96.5 d](/filings/0001193125-26-427907.md) | [107 d](/filings/0001193125-26-046377.md) | [(6.2)](/filings/0001193125-26-170597.md) | [58.0 d](/filings/0001193125-26-323941.md) | [50.7 d](/filings/0001193125-26-427907.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,325](/filings/0000950170-24-012245.md) | [1,578](/filings/0000950170-25-014412.md) | [1,789](/filings/0001193125-26-046377.md) | [1,903](/filings/0001193125-26-046377.md) | [1,894](/filings/0001193125-26-046377.md) |
| Gross margin | % | [18.9%](/filings/0000950170-24-012245.md) | [22.6%](/filings/0000950170-25-014412.md) | [24.2%](/filings/0001193125-26-046377.md) | [24.7%](/filings/0001193125-26-046377.md) | [23.0%](/filings/0001193125-26-046377.md) |
| Operating margin | % | [3.9%](/filings/0000950170-24-012245.md) | [11.1%](/filings/0000950170-25-014412.md) | [12.0%](/filings/0001193125-26-046377.md) | [9.8%](/filings/0001193125-26-046377.md) | [9.1%](/filings/0001193125-26-046377.md) |
| Net margin | % | [1.2%](/filings/0000950170-24-012245.md) | [8.0%](/filings/0000950170-25-014412.md) | [5.9%](/filings/0001193125-26-046377.md) | [6.9%](/filings/0001193125-26-046377.md) | [5.8%](/filings/0001193125-26-046377.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [124](/filings/0000950170-24-012245.md) | [96.8](/filings/0000950170-25-014412.md) | [149](/filings/0001193125-26-046377.md) | [203](/filings/0001193125-26-046377.md) | [157](/filings/0001193125-26-046377.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/hxl/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-26 | [Keating Neal J.](/insiders/1319629.md) | Director | Purchase (P) | 3,000 | $80.67 | $242.0k | [Form 4](/filings/0001193125-26-436418.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.42bn | 14,218,892 |  | Added +1,342,438 |
| [EARNEST PARTNERS LLC](/funds/1102578.md) | 2026-06-30 | $458.7m | 4,584,594 |  | Reduced −120,150 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $437.6m | 4,373,328 |  | Reduced −393,620 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $340.5m | 3,402,558 |  | Added +4,484 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $314.5m | 3,143,027 |  | Added +12,316 |
| [MASSACHUSETTS FINANCIAL SERVICES CO /MA/](/funds/912938.md) | 2026-06-30 | $247.3m | 2,471,596 |  | Added +71,477 |
| [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $216.9m | 2,168,182 |  | Reduced −96,245 |
| [BRANDES INVESTMENT PARTNERS, LP](/funds/1015079.md) | 2026-06-30 | $213.6m | 2,134,549 |  | Reduced −99,776 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $171.2m | 1,710,646 |  | Added +223,895 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $169.4m | 1,693,254 |  | Reduced −184,796 |

## Recent filings

[All 1,770 filings](/companies/hxl/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-21 | 16:35 ET | [10-Q](/filings/0001193125-26-427907.md) | Quarterly report, period 2026-09-30 | 0001193125-26-427907 |
| 2026-10-21 | 16:25 ET | [8-K](/filings/0001193125-26-427875.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-427875 |
| 2026-07-29 | 16:35 ET | [10-Q](/filings/0001193125-26-323941.md) | Quarterly report, period 2026-06-30 | 0001193125-26-323941 |
| 2026-07-29 | 16:25 ET | [8-K](/filings/0001193125-26-323808.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-323808 |
| 2026-05-28 | 16:31 ET | [8-K](/filings/0001140361-26-023151.md) | 1.02 Termination of a material agreement | 0001140361-26-023151 |
| 2026-05-15 | 09:16 ET | [8-K](/filings/0001140361-26-021511.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-021511 |
| 2026-04-30 | 16:46 ET | [8-K](/filings/0001140361-26-018290.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-018290 |
| 2026-04-22 | 16:35 ET | [10-Q](/filings/0001193125-26-170597.md) | Quarterly report, period 2026-03-31 | 0001193125-26-170597 |
| 2026-04-22 | 16:30 ET | [8-K](/filings/0001193125-26-170559.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-170559 |
| 2026-04-01 | 09:09 ET | [DEF 14A](/filings/0001193125-26-135884.md) | Proxy statement, period 2026-05-14 | 0001193125-26-135884 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-046377.md), filed Feb 11, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 717605
- Tickers: HXL
- Exchange: NYSE
- SIC code: 2821 Plastic Materials, Synth Resins & Nonvulcan Elastomers
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 04:32 ET. No prices; not investment advice.